Open an account

Clover Health Investments

CLOV · NASDAQ

$4.80+$0.36 (+8.11%)TodayMarket closed ·
Prev close $4.44

About CLOV

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. The company is headquartered in Jersey City, New Jersey and currently employs 724 full-time employees. The company went IPO on 2020-06-12. The firm is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.

Employees
724
Headquarters
Jersey City, New Jersey
Listed
Jun 12, 2020
Sector
Health Care
Industry
Health Care Providers & Services
Website
cloverhealth.com

CLOV key statistics

Market cap
2.55B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
4.24M
Volume
3.50M
Open price
$4.47
High today
$4.81
Low today
$4.43
52 Week high
$5.59
52 Week low
$1.58

Clover Health Investments (CLOV) at a glance

As of Oct 20, 2026, Clover Health Investments (CLOV) shares are priced at $4.80, giving the company a market cap of 2.55B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $4.43 and $4.81. The current price is 8.4% above the day's low and 0.2% below its high.

Volume so far is 3.50M shares, in line with the average of 4.24M shares a day.

Over the past year Clover Health Investments has ranged from $1.58 to $5.59, and now sits 80% of the way up that range.

Clover Health Investments met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.05 per share against an estimate of $0.034.

The average analyst price target is $4.74, 1.2% below the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

33%of 3 analyst ratings say Buy
  • Buy33.3%
  • Hold66.7%
  • Sell0.0%
Price target · 7 analystsAvg $4.74
Low
$1.77
Now
$4.80
High
$6.30

CLOV earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 57.2% on average.

  1. Q3 FY24: reported -$0.02 per share against an estimate of -$0.0408
  2. Q4 FY24: reported -$0.04 per share against an estimate of -$0.0663
  3. Q1 FY25: reported $0.00 per share against an estimate of -$0.0578
  4. Q2 FY25: reported -$0.02 per share against an estimate of -$0.0281
  5. Q3 FY25: reported -$0.05 per share against an estimate of -$0.0306
  6. Q4 FY25: reported -$0.10 per share against an estimate of -$0.1054
  7. Q1 FY26: reported $0.07 per share against an estimate of $0.0306
  8. Q2 FY26: reported $0.05 per share against an estimate of $0.034

CLOV news

  • Press releaseGlobe Newswire

    Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States

  • Erica Kollmann

    QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins

  • Evette Mitkov

    Clover Health Stock Pops: What's Happening?

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseGlobe Newswire

    Clover Health Reports Second Quarter 2026 Results

  • Vandana Singh

    Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit

  • Dylan Berman

    Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating

  • Press releasePRNewswire

    MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

Similar companies

Companies in the same industry as Clover Health Investments

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.